Rechallenge Decisions

Rechallenge Decisions is a clinical decision-making framework in hypersensitivity reaction management within multidisciplinary cardio-oncology care that determines the safety and appropriateness of reintroducing a previously implicated therapeutic agent after an adverse reaction, based on risk stratification, multidisciplinary evaluation, and patient-specific factors.

5

Publications

506

Citations

36

Authors

25

Institutions

Publications per year

2017–2026

2

Authors

36

  1. BM
    B. Milpied

    Hôpital Saint-André, France

    1 publications · 25 citations

    1

    h-index

  2. PW
    P. Wolkenstein

    Université Paris-Est Créteil, France

    1 publications · 25 citations

    1

    h-index

  3. OC
    O. Chosidow

    Université Paris-Est Créteil, France

    1 publications · 25 citations

    1

    h-index

  4. BS
    B. Sassolas

    Centre Hospitalier Régional Universitaire de Brest, France

    1 publications · 25 citations

    1

    h-index

  5. FT
    F. Tétart

    Inserm, France

    1 publications · 25 citations

    1

    h-index

1–5 of 36

Venues

  1. BMJ

    1 publications · 33 citations

    1

    h-index

  2. The Canadian Journal of Psychiatry

    CJP · 1 publications · 22 citations

    1

    h-index

  3. PubMed

    Repository · 1 publications · 103 citations

    1

    h-index

  4. Hepatology

    1 publications · 323 citations

    1

    h-index

  5. British Journal of Dermatology

    1 publications · 25 citations

    1

    h-index

1–5